Evidence map›Paper›PMID 37323271›Full record

ArticleClinical case reports2023

Recurring nodular scleritis following inactivated vaccination for COVID-19.

Alireza Peyman, Mohsen Pourazizi, Shakiba Dehghani, Sarah Ghorbani

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical case reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Alireza PeymanDepartment of Ophthalmology, Isfahan Eye Research Center Isfahan University of Medical Sciences Isfahan Iran.ORCID https://orcid.org/0000-0001-7687-8811
Mohsen PouraziziDepartment of Ophthalmology, Isfahan Eye Research Center Isfahan University of Medical Sciences Isfahan Iran.ORCID https://orcid.org/0000-0002-9714-8209
Shakiba DehghaniDepartment of Ophthalmology, Farabi Eye Hospital Tehran University of Medical Science Tehran Iran.ORCID https://orcid.org/0000-0002-6508-778X
Sarah GhorbaniDepartment of Ophthalmology, Isfahan Eye Research Center Isfahan University of Medical Sciences Isfahan Iran.ORCID https://orcid.org/0000-0001-5921-6410
Isfahan University of Medical Sciences · IRUniversity of Tehran · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Key Clinical Message: Though COVID-19 vaccination saved many lives all around the world, it has had many adverse effects including ophthalmologic side effects. It is important to report such adverse effects to provide timely diagnosis and management. Abstract: Since the COVID-19 global outbreak, many types of vaccines have been introduced. These vaccines have been associated with some adverse effects including ocular manifestations. Herein, we report a case of a patient who developed nodular scleritis shortly after receiving the first and second doses of the inactivated COVID-19 vaccine, Sinopharm.

Indexed as

coronavirus disease‐2019COVID‐19 vaccinescleritisSinopharm

Identifiers

PMID37323271
PMCPMC10264956
OpenAlexW4380684210

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.